Exit Notice
You are about to leave ClinicalTrials.gov and go to: A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer URL: https://trials.lilly.com/en-US/trial/230195
Click on the link to continue or return to ClinicalTrials.gov Home